Here are what the editors at HealthDay consider to be the most important developments in Allergy for September 2008. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
News Media Under-Report Drug Company Funding of Research
TUESDAY, Sept. 30 (HealthDay News) -- Reports on medication research published in general news media often fail to disclose that the research received pharmaceutical company funding and frequently refer to drugs by brand name rather than using the generic name, according to an article published in the Oct. 1 issue of the Journal of the American Medical Association.
Abstract
Full Text (subscription or payment may be required)
No Change to 2009 Part B Medicare Premium
MONDAY, Sept. 22 (HealthDay News) -- There will be no change to the Part B Standard Medicare premium in 2009 compared with 2008. This is the first time since 2000 that the premium has not risen over the prior year, according to an announcement by the Department of Health and Human Services' Centers for Medicare & Medicaid Services (CMS).
More Information
Childhood Paracetamol Use Linked to Later Asthma Symptoms
FRIDAY, Sept. 19 (HealthDay News) -- The use of paracetamol (acetaminophen), whether in the first year of life or later in childhood, is associated with higher risk of asthma symptoms at ages 6 and 7, according to research published in the Sept. 20 issue of The Lancet.
Abstract
Full Text (subscription or payment may be required)
Measuring Exhaled NO Adds Little to Asthma Treatment
FRIDAY, Sept. 19 (HealthDay News) -- Regularly measuring fraction of exhaled nitric oxide (NO) didn't lead to improvement in asthma symptoms or lung function in young patients with asthma, according to research published in the Sept. 20 issue of The Lancet.
Abstract
Full Text (subscription or payment may be required)
Editorial
Several Risk Factors Linked to Adult-Onset Asthma
FRIDAY, Sept. 19 (HealthDay News) -- Factors associated with asthma diagnosed in adulthood include persistent wheezing in early life, bronchial hyper-responsiveness at 6 years of age, and allergic or non-allergic rhinitis in adulthood, according to the results of two studies published in the Sept. 20 issue of The Lancet.
Abstract - Stern
Full Text (subscription or payment may be required)
Abstract - Shaaban
Full Text (subscription or payment may be required)
Editorial
Antibiotic Resistance Has Become a Global Pandemic
FRIDAY, Sept. 19 (HealthDay News) -- A concerted international and national response, behavior change by consumers and providers, and the development of antibacterial agents are all urgently needed to tackle the global problem of rapidly increasing antibiotic resistance, according to an article published online Sept. 18 in BMJ.
Abstract
Full Text (subscription or payment may be required)
Obesity Linked to Poor Asthma Outcomes
THURSDAY, Sept. 11 (HealthDay News) -- Obese individuals with asthma are more likely to have poor asthma outcomes and more asthma-related hospitalizations than normal-weight individuals, according to a study published online in September in the Journal of Allergy and Clinical Immunology.
Abstract
Full Text (subscription or payment may be required)
Low Sweat Production Linked to Exercise-Induced Asthma
WEDNESDAY, Sept. 10 (HealthDay News) -- Decreased sweat secretion rates are associated with positive response to methacholine challenge testing among patients with suspected exercise-induced asthma, according to a report in the September issue of Chest.
Abstract
Full Text (subscription or payment may be required)
Physical, Sexual Abuse Linked to Asthma in Children
FRIDAY, Sept. 5 (HealthDay News) -- Puerto Rican children are more likely to have asthma if they have been a victim of physical or sexual abuse, according to a study published in the Sept. 1 issue of the American Journal of Respiratory and Critical Care Medicine.
Abstract
Full Text (subscription or payment may be required)
Review Finds No Link Between Montelukast, Suicide
FRIDAY, Sept. 5 (HealthDay News) -- Although media reports have questioned a link between montelukast use and suicide, three randomized trials didn't find that reduced emotional well-being is an adverse effect of the drug, according to a review published online Aug. 29 in the Journal of Allergy and Clinical Immunology.
Full Text (subscription or payment may be required)
Potential Vaccine Reactions Call for Reasoned Approach
THURSDAY, Sept. 4 (HealthDay News) -- Evaluating possible vaccine-related hypersensitivity reactions -- which are a relatively common clinical problem -- is the first step for health care providers to take in minimizing future problems in these patients, according to an article in the September issue of Pediatrics.
Abstract
Full Text
Human Papillomavirus Vaccine Linked to Anaphylaxis Risk
WEDNESDAY, Sept. 3 (HealthDay News) -- While the risk of anaphylaxis was higher in a human papillomavirus (HPV) vaccination program compared to a similar program for meningococcal vaccination, HPV vaccination is remarkably safe, according to an article published online Sept. 1 in CMAJ, the Canadian Medical Journal.
Abstract
Full Text (subscription or payment may be required)
Editorial
Editorial
